Plexus Earnings Call Signals Growth-Focused Expansion

Plexus ((PLXS)) has held its Q2 earnings call. Read on for the main highlights of the call.

Plexus’ latest earnings call carried a clearly upbeat tone as management highlighted accelerating revenue, record new business wins and improving profitability that beat guidance. Executives acknowledged temporary growing pains in working capital, supply chains and ramp-related costs, but emphasized that these are manageable trade-offs to support a higher, more durable growth trajectory.

Revenue Growth Accelerates With Strong Q3 Outlook

Fiscal Q2 revenue reached $1.164 billion, up 19% year over year and marking the fifth straight quarter of sequential growth. Management guided Q3 revenue to $1.2–$1.25 billion, implying roughly 20% annual growth at the midpoint and about 5% sequential expansion as program ramps continue.

Record Program Wins Fuel Expanding $4 Billion Funnel

Plexus booked a record $355 million of annualized new manufacturing program wins across 30 programs in Q2, underlining strong customer demand. The qualified opportunity funnel grew 11% sequentially to $4.0 billion, with aerospace & defense and industrial opportunities each expanding more than 45% versus last year.

Industrial And Aerospace & Defense Drive Sector Momentum

Industrial revenue climbed 12% sequentially in Q2, aided by record sector wins of $195 million in areas such as data center power and robotics. Aerospace & defense revenue jumped 19% sequentially, with $44 million in new wins and expectations for that sector to post well into double-digit growth into fiscal 2026.

Healthcare And Life Sciences Poised To Reaccelerate

Healthcare/Life Sciences posted $116 million in Q2 wins, including point-of-care ultrasound and robotic surgical platforms that expand Plexus’ exposure to advanced medical technology. While revenue was essentially flat sequentially, management expects growth to resume into Q4 and sees fiscal 2026 sector growth above the company’s 9%–12% long-term goal.

Margins And Earnings Top Guidance

Profitability outperformed expectations, with non-GAAP operating margin hitting 6%, the top end of guidance, and non-GAAP EPS of $2.05 above the company’s range. Gross margin of 10.2% also landed at the high end of guidance, demonstrating improving mix and leverage even as the company invests for future growth.

Cash Generation And Balance Sheet Strengthen

Operating cash flow in Q2 was $28.5 million and capital expenditures were $12.5 million, producing $16 million of free cash flow that beat internal forecasts. Plexus ended the quarter in a net cash position, repurchased about 109,000 shares for $20.6 million and improved its cash cycle to 64 days, five days better sequentially.

Return On Capital Remains Well Above Hurdle Rate

Plexus delivered a Q2 return on invested capital of 13.8%, standing 480 basis points above its weighted average cost of capital. Management framed this spread as evidence that incremental investments to support growth are generating attractive economic returns despite higher working capital needs.

Working Capital To Rise As Growth Ramps

Management signaled that supporting faster revenue growth will require more working capital, leading to near-term cash usage in Q3 after the current net cash position. The company expects its cash cycle to stretch to 67–71 days in Q3, with free cash flow turning negative temporarily before improving again over time.

Supply Chain Tightening Brings Execution Risk

Plexus noted emerging tightness in several components, including semiconductors, passives, memory, PCB fabrication, magnetics and certain microcontrollers. Extended lead times and potential allocations could constrain some ramps, prompting the company to step up proactive supply-chain mitigation to protect schedules and customer commitments.

Ramps And Investments Create Near-Term Margin Drag

Q3 gross margin is guided to 9.9%–10.2%, slightly softer at the midpoint than Q2, as new program ramps and capability investments weigh on profitability. Higher incentive compensation also pressures margins, but management stressed that ramp-related costs should translate into stronger operating leverage once volumes mature.

Higher SG&A And Non-Operating Costs Weigh On Earnings

Selling and administrative expense reached $57.3 million in Q2, modestly above guidance due to incentive pay and increased technology and automation spending. Non-operating expense is projected to rise to about $5.4 million in Q3, driven by higher interest costs and tougher foreign-exchange comparisons that will slightly trim EPS.

Malaysia Facility Lags But Set To Improve

The Malaysia site remained slightly below breakeven during Q2 as revenue ramped faster than expected while early-stage investments continued. Management expects profitability at this facility to improve by year-end, arguing that these up-front costs position the location for stronger returns as volumes scale.

Long Ramp Cycles Delay Full Revenue Realization

Executives cautioned that new program ramps vary significantly by customer and sector, with some taking six to eight quarters to reach steady-state production. As a result, a meaningful portion of revenue from recent record wins may not fully benefit financials until fiscal 2027 and beyond, extending the growth runway.

Guidance Points To Robust Multi-Year Growth

Looking ahead, Plexus guided Q3 revenue to $1.20–$1.25 billion, a non-GAAP operating margin of 5.9%–6.3% and EPS of $2.02–$2.18, with gross margin near 10% and a tax rate of 16%–18%. For fiscal 2026, the company now targets mid-teens or higher revenue growth, operating margin above 6%, double-digit expansion across all sectors and $50–$75 million of free cash flow despite planned capital spending of $100–$120 million.

Plexus’ earnings call painted the picture of a company leaning into growth, with strong demand, record wins and above-plan profitability offsetting near-term cash and margin pressures. For investors, the message was that working capital and ramp costs are the price of capturing a sizable opportunity pipeline that could support elevated growth and solid returns well into the back half of the decade.